$3.74
-0.02-0.53%
Last update: Dec 16, 10:56 AM
Comments
Loading...
X4 Pharmaceuticals Stock Guidance | NASDAQ:XFOR | Benzinga
X4 Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
FAQ
What is the most recent guidance for X4 Pharmaceuticals (XFOR)?
There have been no specific sales or earnings guidance reported for X4 Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
